AI in healthcare. With evidence.
From medicines to biobanks: research, applications and their limitations, explored through trusted sources.
Selected articles are also available in Estonian and Polish. Other articles open in Turkish or English.
AI clinical trial matching: from prescreening to human review
Suggesting a clinical trial does not establish eligibility. The 2024 TrialGPT study and NLM’s explanations help clarify AI’s role in drug research and the limits of the evidence.
Read article and sources ↗
AI antibiotic discovery: what do explainable models add?
Understanding why a molecule was selected can help researchers investigate new antibiotic candidates. Separating explainable AI, experimental evidence and the remaining steps towards clinical use.
Read article and sources ↗AI drug discovery: from molecules to clinical evidence
Designing a drug candidate with AI does not establish patient benefit. We read a phase 2a study alongside EMA’s approach to evaluating AI.
Read article and sources ↗Our editorial approach: primary sources, explicit references and the limits of the evidence. AI-assisted editorial content; not individual medical advice.